Nab-Paclitaxel for Metastatic Pancreatic Cancer: Clinical Outcomes and Potential Mechanisms of Action

Salah-Eddin Al-Batran; Michael Geissler; Thomas Seufferlein; Helmut Oettle

doi:10.1159/000358890

Nab-Paclitaxel for Metastatic Pancreatic Cancer: Clinical Outcomes and Potential Mechanisms of Action

Oncology Research and Treatment ◽

10.1159/000358890 ◽

2014 ◽

Vol 37 (3) ◽

pp. 128-134 ◽

Cited By ~ 16

Author(s):

Salah-Eddin Al-Batran ◽

Michael Geissler ◽

Thomas Seufferlein ◽

Helmut Oettle

Keyword(s):

Pancreatic Cancer ◽

Clinical Outcomes ◽

Mechanisms Of Action ◽

Metastatic Pancreatic Cancer

Download Full-text

Treatment patterns and clinical outcomes in patients with metastatic pancreatic cancer treated with first-line nab-paclitaxel plus gemcitabine: Analysis of US electronic health records from the Flatiron Health Database

Annals of Oncology ◽

10.1093/annonc/mdx261.214 ◽

2017 ◽

Vol 28 ◽

pp. iii77-iii78

Author(s):

Dawn Flick Elizabeth ◽

Jack Shiansong Li ◽

Gilbert Jirau-Lucca ◽

Michael Ondovik ◽

Melissa Nifenecker ◽

...

Keyword(s):

Pancreatic Cancer ◽

Electronic Health Records ◽

Clinical Outcomes ◽

Treatment Patterns ◽

Metastatic Pancreatic Cancer ◽

First Line ◽

Health Records ◽

Electronic Health ◽

Health Database

Download Full-text

Clinical Outcomes with First-Line Chemotherapy in a Large Retrospective Study of Patients with Metastatic Pancreatic Cancer Treated in a US Community Oncology Setting

Drugs - Real World Outcomes ◽

10.1007/s40801-018-0137-x ◽

2018 ◽

Vol 5 (3) ◽

pp. 149-159 ◽

Cited By ~ 14

Author(s):

Thomas H. Cartwright ◽

Monika Parisi ◽

Janet L. Espirito ◽

Thomas W. Wilson ◽

Corey Pelletier ◽

...

Keyword(s):

Pancreatic Cancer ◽

Retrospective Study ◽

Clinical Outcomes ◽

Metastatic Pancreatic Cancer ◽

First Line ◽

Community Oncology ◽

Large Retrospective Study ◽

Line Chemotherapy

Download Full-text

Clinical Outcomes of Intraoperative Radiation Therapy, Postoperative Radiation Therapy, and Definitive Radiation Therapy for Non-Metastatic Pancreatic Cancer

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2018.07.439 ◽

2018 ◽

Vol 102 (3) ◽

pp. e81-e82

Author(s):

T. Yanagi ◽

N. Takama ◽

E. Kato ◽

F. Baba ◽

M. Shimohira ◽

...

Keyword(s):

Pancreatic Cancer ◽

Radiation Therapy ◽

Clinical Outcomes ◽

Metastatic Pancreatic Cancer ◽

Intraoperative Radiation Therapy ◽

Postoperative Radiation ◽

Postoperative Radiation Therapy ◽

Intraoperative Radiation

Download Full-text

Clinical outcomes of FOLFIRINOX and gemcitabine–nab paclitaxel for metastatic pancreatic cancer in the real world setting

Clinical & Translational Oncology ◽

10.1007/s12094-020-02473-w ◽

2020 ◽

Cited By ~ 1

Author(s):

F. Franco ◽

J. C. Camara ◽

J. I. Martín-Valadés ◽

A. López-Alfonso ◽

D. Marrupe ◽

...

Keyword(s):

Pancreatic Cancer ◽

Clinical Outcomes ◽

Real World ◽

Metastatic Pancreatic Cancer ◽

The Real ◽

Real World Setting

Download Full-text

Clinical outcomes of first line FOLFIRINOX vs. gemcitabine plus nab-paclitaxel in metastatic pancreatic cancer at the Yale Smilow Hospital System

Journal of Gastrointestinal Oncology ◽

10.21037/jgo-21-202 ◽

2021 ◽

Vol 0 (0) ◽

pp. 0-0

Author(s):

Timil Patel ◽

Joseph Miccio ◽

Michael Cecchini ◽

Thejal Srikumar ◽

Stacey Stein ◽

...

Keyword(s):

Pancreatic Cancer ◽

Clinical Outcomes ◽

Metastatic Pancreatic Cancer ◽

First Line ◽

Hospital System

Download Full-text

Serum CA19-9 Decline Compared to Radiographic Response as a Surrogate for Clinical Outcomes in Patients With Metastatic Pancreatic Cancer Receiving Chemotherapy

Pancreas ◽

10.1097/mpa.0b013e31816d8185 ◽

2008 ◽

Vol 37 (3) ◽

pp. 269-274 ◽

Cited By ~ 58

Author(s):

Derrick Wong ◽

Andrew H. Ko ◽

Jimmy Hwang ◽

Alan P. Venook ◽

Emily K. Bergsland ◽

...

Keyword(s):

Pancreatic Cancer ◽

Clinical Outcomes ◽

Metastatic Pancreatic Cancer ◽

Radiographic Response

Download Full-text

High Dose Ascorbic Acid and Nanoparticle Paclitaxel Protein Bound and Cisplatin and Gemcitabine (AA NABPLAGEM) in Patients Who Have Metastatic Pancreatic Cancer

Case Medical Research ◽

10.31525/ct1-nct03908333 ◽

2019 ◽

Author(s):

Keyword(s):

Pancreatic Cancer ◽

Ascorbic Acid ◽

Metastatic Pancreatic Cancer ◽

High Dose

Download Full-text

An Open-label, Phase I/II Study of the Pan-immunotherapy in Patients With Local Advanced/Metastatic Pancreatic Cancer

Case Medical Research ◽

10.31525/ct1-nct03989310 ◽

2019 ◽

Author(s):

Keyword(s):

Pancreatic Cancer ◽

Phase I ◽

Metastatic Pancreatic Cancer ◽

Open Label ◽

Open Label Phase ◽

Local Advanced

Download Full-text

Faculty Opinions recommendation of FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.10667956.11678055 ◽

2011 ◽

Author(s):

Weijing Sun ◽

Davendra Sohal

Keyword(s):

Pancreatic Cancer ◽

Metastatic Pancreatic Cancer

Download Full-text

Faculty Opinions recommendation of A randomized, placebo-controlled phase 2 study of ganitumab (AMG 479) or conatumumab (AMG 655) in combination with gemcitabine in patients with metastatic pancreatic cancer.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717952475.793457945 ◽

2012 ◽

Author(s):

Josep Tabernero ◽

Elena Elez

Keyword(s):

Pancreatic Cancer ◽

Metastatic Pancreatic Cancer ◽

Phase 2 ◽

Phase 2 Study

Download Full-text